[Skip to content]

Print this page
.

Local network haematology regimens

Ruxolitinib

Ruxolitinib
Summary: For treatment of symptomatic splenomegaly in primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis
File Size: 44KB
File Type: application/pdf
Created: 05 July 2013
Last Modified: 22 July 2016